Arndt, C.A., Stoner, J.A., Hawkins, D.S., Rodeberg, D.A., Hayes-Jordan, A.A., Paidas, C.N., Parham, D.M., Teot, L.A., Wharam, M.D., Breneman, J.C., Donaldson, S.S., Anderson, J.R. and Meyer, W.H. (2009) Vincristine, Actinomycin, and Cyclophosphamide Compared with Vincristine, Actinomycin, and Cyclophosphamide Alternating with Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children’s Oncology Group Study D9803. Journal of Clinical Oncology, 27, 5182-5188. http://dx.doi.org/10.1200/JCO.2009.22.3768

has been cited by the following article:

• TITLE: Adult Primary Prostate Embryonal Rhabdomyosarcoma: Report of a Case and Revue of Literature

  AUTHORS: Lamiae Amaadour, Yassir Tahiri, Hassania Ameurtesse, Moustapha Ahssaini, Zineb Benbrahim, Taoufik Harmouche, Samia Arifi, Jalaleddine El Ammari, Nawfel Mellas

  KEYWORDS: Prostate Rhabdomyosarcoma, Multimodal Therapy, Adult

  JOURNAL NAME: Journal of Cancer Therapy, Vol.5 No.6, May 26, 2014

  ABSTRACT: Introduction: Primary embryonal rhabdomyosarcoma of prostate (ERMP) is an extremely rare pathological and clinical entity in adults. It’s characterized by extensive loco-regional spread and a tendency to metastasize by blood stream and regional lymphatics. In adult patients, data available on the management of ERMP are limited and mostly derived from the pediatric clinical trials on rhabdomyosarcoma. Case Report: We report a case of group III ERMP approached by initial surgery followed by the administration of three courses of vincristine, doxorubicin and Cyclophosphamide regimen. The patient succumbed to disease complications three months after the original diagnosis. Conclusion: The most appropriate therapeutic approach for adults with ERMP remains questionable. Further studies are needed to improve the understanding of biological behavior of ERMP in adults and to define the best therapeutic strategy in locally advanced disease.